Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Proposed Federal Budget For Alzheimer’s Research May Rise by Over 50 Percent

Alzheimer's WordsWashington, DC, December 17, 2015 The Washington Post reports that the spending deal Congress reached Tuesday night includes an unprecedented increase in funding for Alzheimer’s research: $350 million in fiscal 2016. If approved by the White House, it will increase government spending on the disease by over 50 percent.

Advocates have long pushed for significant increases in Alzheimer’s spending, calling it a coming crisis and saying it should be funded at the same level as cancer, HIV/AIDS and heart disease research.

A panel of scientists convened by the Alzheimer’s Association estimated that the National Institutes of Health (NIH) would need $2 billion a year to maximize the chances of curing or preventing the disease by 2025. This year’s increase puts the NIH well on its way toward that goal.

If each year the funding is increased by $350 million, he noted, the $2 billion goal would be reached by 2020.

That is significant, advocates say, because the United States faces a ticking time bomb in terms of the financial and personal costs of Alzheimer’s.

By 2025, the number of people age 65 and older with Alzheimer’s is estimated to reach 7.1 million — a 40 percent increase from 5.1 million today, according to the Alzheimer’s Association.

Spending on Alzheimer’s and other dementias is $226 billion a year, over two-thirds of which comes from Medicare and Medicaid.

For the full Washington Post story, click here.